In recent years, the R&D and innovation of domestic medical device companies has become stronger and stronger, providing opportunies for import substitution.
On August 30, the new product launch of Innolcon "Ultrasonic Surgical System" was held in Suzhou, with the release of its latest scientific achievements.
Another new domestic medical equipment launched
Innolcon "Ultrasonic Surgical System" obtained NMPA certification of Class III medical device (vessel sealing diameter ≤5mm), which was the first domestic enterprise to be granted the certificate, comparable to major international enterprises in quality level. This meant that import substitution was more and more prominent in the golden decade of innovation.
News & Information
Academic Activities